Kuang, Bai, Fang, Lopez, Yang, Tong, Wang, Garcia-Manero: "Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia." in: Blood, Vol. 115, Issue 12, pp. 2412-9, 2010 (PubMed).
Suzuki, Abe, Imagama, Nomura, Tanizaki, Minami, Hayakawa, Ito, Katsumi, Yamamoto, Emi, Kiyoi, Naoe: "BCR-ABL-independent and RAS / MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4." in: European journal of haematology, Vol. 84, Issue 3, pp. 229-38, 2010 (PubMed).
Weinsheimer, Kim, Pawlikowska, Chen, Lawton, Sidney, Kwok, McCulloch, Young: "EPHB4 gene polymorphisms and risk of intracranial hemorrhage in patients with brain arteriovenous malformations." in: Circulation. Cardiovascular genetics, Vol. 2, Issue 5, pp. 476-82, 2009 (PubMed).
Kwan Tat, Pelletier, Amiable, Boileau, Lavigne, Martel-Pelletier: "Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes." in: Arthritis research & therapy, Vol. 11, Issue 4, pp. R119, 2009 (PubMed).
Pennisi, Ling, Li, Khan, Shaughnessy, Barlogie, Yaccoby: "The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth." in: Blood, Vol. 114, Issue 9, pp. 1803-12, 2009 (PubMed).